Professor Peter Vangheluwe’s team received support from the Michael J. Fox Foundation for research rejected by other funders. Having subsequently achieved a significant scientific breakthrough, he is convinced that informed charity funders play a vital role in accelerating development of a cure.
Neuropharmacologist Ian Reynolds talks about how Parkinson’s Disease research has changed over his career, his expectations for a cure and the importance of charitable funding.
AC Immune’s Chief Scientific Officer, Dr. Marie H. Kosco-Vilbois discusses how the development of a diagnostic tool to safely and effectively diagnose and monitor Parkinson’s Disease can support research into pioneering treatments.
UCal researcher Hao Qian talks about his team’s success in curing mice with Parkinson’s Disease by replacing the dopamine-producing cells that are destroyed by the condition, but says a great deal more research is needed before being able to be sure that the process will work as well in humans.
It has taken years of painstaking research to achieve an important scientific discovery with the potential to improve diagnostics, treatment and perhaps even a cure for Parkinson’s Disease, however the KU Leuven team know that more patient detective work is still needed and funding is key!
We asked Shaun Martin PhD, a senior postdoctural scientist researching Parkinson’s Disease at KU Leuven, to tell us more about his role, motivation and research. His responses were both eye-opening and touching. Read his full interview here.
Sarah van Veen remembers the moment her lab experiment went blue, as if it was yesterday! It was September 2016 and she was two years into her biomedical science doctorate studying how a dysfunctional protein in brain cells contributed to the development of Parkinson’s Disease. “I wasn’t really expecting to see blue that … Continued